Recent headlines have ignited significant questioning regarding Wockhardt’s cough medication, specifically concerning the detection of harmful levels of the substance and potentially contaminants. While the company previously claimed its adherence to standards, various occurrences of adverse outcomes, including critical impairment and potentially